Phase transformation considerations during process development and manufacture of solid oral dosage forms |
| |
Authors: | Zhang Geoff G Z Law Devalina Schmitt Eric A Qiu Yihong |
| |
Institution: | Pharmaceutics and New Technology Center, R4P3/AP9, Global Pharmaceutical R&D, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6120, USA. Qiu.yihong@abbott.com |
| |
Abstract: | The quality and performance of a solid oral dosage form depends on the choice of the solid phase, the formulation design, and the manufacturing process. The potential for process-induced solid phase transformations must be evaluated during design and development of formulations and manufacturing processes. This article briefly reviews the basic principles of polymorphism, defines the classes of phase transformation and the underlying transformation mechanisms, and discusses respective kinetic factors. The potential phase transformations associated with common unit operations employed in manufacturing solid oral dosage forms are highlighted. Specific examples are given to illustrate the importance of solid phases, and process-induced phase transitions in formulation and process development. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|